Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T16:53:41.705Z Has data issue: false hasContentIssue false
  • English
  • Français

Setting Research Priorities: Human Germ-Line Gene Therapy in Perspective

Published online by Cambridge University Press:  17 May 2016

Robert H. Blank
Robert H. Blank*
Affiliation:
University of Canterbury, New Zealand
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium: Regulating Germ-Line Gene Therapy
Information
Politics and the Life Sciences , Volume 13 , Issue 2 , August 1994 , pp. 221 - 222
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Blank, R.H. (1992). “The Limits of Technology Assessment: Values, Time Frame and Public Expectations.” In Bryner, G.(ed.), Science, Technology, and Politics: Policy Analysis in Congress. Boulder, CO: Westview.Google Scholar
Bonnicksen, A.L. (1994). “National and International Approaches to Human Germ-Line Gene Therapy.” Politics and the Life Sciences 13:39–49.Google Scholar
Mathieu, D. (1993). “Ending the Experiment: Dilemmas of the Experimental/Therapeutic Distinction.” In Blank, R.H. and Bonnicksen, A.L.(eds.), Emerging Issues in Biomedical Policy, Volume 2. New York: Columbia University Press.Google Scholar